| Date | Subject |
| 01/31/2012 02:12:30 PM | |
| FDA Approves Ivacaftor to Treat Rare Form of Cystic Fibrosis |
| 01/31/2012 02:09:52 PM | |
| FDA Approves New Combination Treatment for Type 2 Diabetes |
| 01/30/2012 12:15:02 PM | |
| FDA Approves Vismodegib for Locally Advanced Basal Cell Carcinoma |
| 01/27/2012 04:38:46 PM | |
| FDA Approves Once-Weekly Treatment for Type 2 Diabetes |
| 01/27/2012 02:40:36 PM | |
| FDA Approves Axitinib for Advanced Renal Cell Carcinoma |
| 01/27/2012 01:02:33 PM | |
| Chemoradiation Improves Outcomes in a Subset of Patients With Head and Neck Cancer: Presented at MHNCS |
| 01/25/2012 03:03:30 PM | |
| Study Supports Mixed Lipid Emulsion to Reverse Toxicity of Local Anaesthetics |
| 01/25/2012 01:17:39 PM | |
| Interferon Beta-1a Approved in the EU for Patients at Risk of Developing MS |
| 01/25/2012 11:39:47 AM | |
| FDA Approves Levetiracetam for Infants With Partial Onset Seizures |
| 01/24/2012 03:18:28 PM | |
| Lansoprazole Not Effective for Children With Poorly Controlled Asthma |
| 01/24/2012 01:28:40 PM | |
| Dutasteride Reduces Need for Aggressive Therapy in Men With Low-Risk Prostate Cancer |
| 01/23/2012 03:14:41 PM | |
| Study of Regorafenib Meets Endpoint of Improving Survival in Metastatic Colorectal Cancer: Presented at ASCO-GI |
| 01/23/2012 02:55:43 PM | |
| Investigative Oral Taxane Shows Promise in the Treatment of Gastro-oesophageal Cancer: Presented at ASCO-GI |
| 01/23/2012 01:16:19 PM | |
| FDA: New Risk Factor for PML Associated With Natalizumab Identified |
| 01/23/2012 12:48:11 PM | |
| Adding Everolimus to Best Supportive Care Fails to Improve Survival in Advanced Gastric Cancer: Presented at ASCO-GI |
| 01/20/2012 12:59:47 PM | |
| EMA Begins Investigation Into the Cardiovascular Effects of Fingolimod |
| 01/19/2012 03:55:45 PM | |
| Use of Antimicrobial Scrubs May Help Decrease Risk of MRSA Transmission |
| 01/19/2012 12:05:36 PM | |
| Combination of Oral Antiviral Agents Can Help Suppress Hepatitis C Virus |
| 01/18/2012 10:53:17 AM | |
| FDA Approves Glucarpidase to Treat Patients With Toxic Methotrexate Levels |
| 01/17/2012 03:12:36 PM | |
| Cangrelor Helps Maintain Platelet Inhibition Prior to Cardiac Surgery |
| 01/16/2012 04:51:16 PM | |
| Studies Help Clarify the Role of Lapatinib, Trastuzumab in HER2-Positive Breast Cancer |
| 01/16/2012 02:57:38 PM | |
| Revolutionary Surgical Technique for Perforations of the Eardrum |
| 01/13/2012 02:12:47 PM | |
| NICE Recommends New Treatment for Chronic Myeloid Leukaemia |
| 01/13/2012 12:44:35 PM | |
| FDA Adds Boxed Warning to Brentuximab Vedotin Label, New Contraindication |
| 01/12/2012 04:13:37 PM | |
| First Detailed Data Shows Risk of Using Aliskiren With ACE Inhibitors or ARBs |
| 01/12/2012 04:05:26 PM | |
| Viral Load a Major Factor Affecting Risk of Sexually Transmitting HIV |
| 01/12/2012 12:59:18 PM | |
| Chemotherapy May Influence Leukaemia Relapse |
| 01/11/2012 04:12:44 PM | |
| NICE Updates Epilepsy Guideline to Include Newer Antiepileptic Drugs |
| 01/11/2012 11:48:38 AM | |
| Novel Deep Brain Stimulation Device Shows Positive Results in Parkinson’s Disease |
| 01/10/2012 03:50:59 PM | |
| Simple Antibiotic Administration Programme Could Enable Elimination of Neglected Yaws Disease |
| 01/10/2012 12:40:29 PM | |
| Vitamin D May Improve Bone Health in Patients With HIV Taking Tenofovir |
| 01/09/2012 03:14:53 PM | |
| Combination Therapy Shows Positive Response for Children With ADHD |
| 01/09/2012 02:59:14 PM | |
| FDA Warns of Opiate Product Mix-Up |
| 01/06/2012 04:19:06 PM | |
| Some Patients With Mild, Moderate Asthma Have Persistent Non-Eosinophilic Disease |
| 01/06/2012 02:54:04 PM | |
| Added Benefit of Linagliptin for Type 2 Diabetes Is Not Proven |
| 01/05/2012 04:24:24 PM | |
| Study Proves Link Between Epstein-Barr Virus and Multiple Sclerosis |
| 01/05/2012 02:41:04 PM | |
| Study Demonstrates Efficacy of Rilonacept in Reducing Gout Flares |
| 01/04/2012 04:19:23 PM | |
| Genital Herpes Can Reactivate Even During High Dose Antiviral Therapy |
| 01/04/2012 04:07:31 PM | |
| New Guidelines Help Physicians Select Proper Antiepileptic Drugs for Patients With HIV |
| 12/29/2011 11:33:36 AM | |
| Bevacizumab Slows Ovarian Cancer Progression, May Improve Survival |
| 12/28/2011 02:54:35 PM | |
| Analysis Does Not Support CYP2C19 Genotyping Before Use of Clopidogrel |
| 12/28/2011 02:44:42 PM | |
| FDA Warns of Potential Injury Due to Two Similar-Sounding Drugs |
| 12/23/2011 11:29:32 AM | |
| Correction of Anaemia After Kidney Transplant Reduces Progression of Allograft Nephropathy |
| 12/20/2011 03:44:15 PM | |
| Aflibercept Reduces Formation of Malignant Ascites in Patients With Ovarian Cancer |
| 12/20/2011 02:57:21 PM | |
| FDA Investigating Death Possibly Related to Fingolimod Treatment for MS |
| 12/19/2011 04:22:09 PM | |
| Most Patients Need Several Sequential Treatment Steps for Remission of Major Depression |
| 12/19/2011 11:33:02 AM | |
| Rivaroxaban Approved in the EU for the Prevention of AF-Related Stroke, Treatment of DVT |
| 12/16/2011 04:41:08 PM | |
| Long-Term Treatment With Lenalidomide and Dexamethasone Effective and Well Tolerated in Patients With Multiple Myeloma: Presented at ASH |
| 12/16/2011 02:48:42 PM | |
| Health Canada Approves Aripiprazole for the Treatment of Schizophrenia in Adolescents |
| 12/16/2011 02:44:50 PM | |
| Safety Profile for Carfilzomib Acceptable for Patients With Late-Stage Multiple Myeloma: Presented at ASH |
| 12/16/2011 02:42:16 PM | |
| Long-Term Inhaled Dry Powder Mannitol Improves Lung Function in Cystic Fibrosis |
| 12/16/2011 01:34:39 PM | |
| EMA Recommends Approval of First-In-Class Treatment for Metastatic or Unresectable Melanoma |
| 12/16/2011 01:32:47 PM | |
| EMA Recommends Authorisation of Vimpat Syrup for Patients Who Cannot Swallow Tablets |
| 12/16/2011 01:30:33 PM | |
| Triple Therapy for Relapsing Multiple Myeloma Falls Short of Expectations in Real-World Study: Presented at ASH |
| 12/16/2011 01:19:40 PM | |
| Deferasirox Reduces Iron Overload in Beta-Thalassaemia Patients not Requiring Transfusions: Presented at ASH |
| 12/16/2011 01:06:41 PM | |
| Multidrug Combination Shows Potent Activity in Newly Diagnosed Multiple Myeloma but With High Toxicity: Presented at ASH |
| 12/16/2011 12:57:21 PM | |
| Response With Carfilzomib/Lenalidomide/Dexamethasone Comparable to Autologous Transplant in Multiple Myeloma: Presented at ASH |
| 12/16/2011 12:28:52 PM | |
| Long-Term Atypical Haemolytic Uremic Syndrome With Renal Damage Responds to Eculizumab: Presented at ASH |
| 12/16/2011 11:31:57 AM | |
| Obesity Linked to Worse Outcomes in Early Breast Cancer Treatment |
| 12/16/2011 11:29:48 AM | |
| Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer |
| 12/15/2011 03:37:01 PM | |
| Blood Levels of VEGF May Predict Response to SSRIs |
| 12/15/2011 02:49:22 PM | |
| Bendamustine Shows Promise in Multiple Myeloma: Presented at ASH |
| 12/15/2011 01:14:02 PM | |
| Adding Bortezomib to Melphalan and Prednisone Shows Overall Mortality Benefit in Multiple Myeloma: Presented at ASH |
| 12/15/2011 12:20:32 PM | |
| Trend for Second Primary Malignancies Among Patients With Multiple Myeloma Requires More Research: Presented at ASH |
| 12/15/2011 11:37:57 AM | |
| Adding Bevacizumab to Chemoradiation Reduces the Spread of Nasopharyngeal Carcinoma |
| 12/15/2011 10:26:13 AM | |
| Health Canada Approves Eribulin for Patients With Metastatic Breast Cancer |
| 12/14/2011 04:04:54 PM | |
| Vaginal Progesterone Reduces Preterm Birth, Neonatal Morbidity and Mortality in Women at Risk |
| 12/14/2011 02:50:57 PM | |
| Retreatment at Symptomatic Relapse as Effective as Maintenance With Rituximab in Follicular Lymphoma: Presented at ASH |
| 12/14/2011 02:48:57 PM | |
| PFS Benefit With Bortezomib Plus Vorinostat Versus Placebo in Multiple Myeloma Patients: Presented at ASH |
| 12/14/2011 02:46:11 PM | |
| Ruxolitinib Survival, Symptom, and Spleen Size Advantage in Myeloproliferative Syndromes: Presented at ASH |
| 12/14/2011 01:22:52 PM | |
| Faster, Deeper Reponses Shown for Patients With CML-CP Using Nilotinib: Presented at ASH |
| 12/14/2011 12:26:09 PM | |
| Post-thrombotic Syndrome Relieved Through Catheter-Based Treatment: Presented at ASH |
| 12/13/2011 12:47:00 PM | |
| Eculizumab Alleviates TMA and Other aHUS Symptoms Long-Term: Presented at ASH |
| 12/13/2011 12:19:19 PM | |
| Nab-Paclitaxel Better Than Docetaxel for Metastatic Breast Cancer: Presented at SABCS |
| 12/13/2011 10:47:58 AM | |
| Single Episode of Malaria in Early Pregnancy Trebles Risk of Miscarriage |
| 12/13/2011 09:45:46 AM | |
| One Dose of Azithromycin Can Prevent Recurrence of Trichiasis for Up to 3 Years After Surgery |
| 12/13/2011 09:43:02 AM | |
| ER Visits for Toxicity Common in Women Receiving Adjuvant Chemotherapy for Breast Cancer: Presented at SABCS |
| 12/13/2011 09:38:00 AM | |
| MRI Detects Asymptomatic Brain Metastases in Women With Advanced Breast Cancer: Presented at SABCS |
| 12/12/2011 03:59:05 PM | |
| Studies Underline Importance of ECG to Evaluate Cardiotoxicity in Patients With Cancer |
| 12/12/2011 03:18:44 PM | |
| Bone Density Testing Suboptimal in Patients With Breast Cancer Receiving Aromatase Inhibitors: Presented at SABCS |
| 12/12/2011 01:12:01 PM | |
| Novel Antibody-Drug Conjugate Shows Promise in HER2-Positive Metastatic Breast Cancer: Presented at SABCS |
| 12/12/2011 11:45:55 AM | |
| Early Zoledronic Acid Provides Long-Term Benefits for Postmenopausal Women With Breast Cancer: Presented at SABCS |
| 12/12/2011 11:40:41 AM | |
| Double Hit of Anti-HER2 Drugs Improves PFS in Metastatic Breach Cancer: Presented at SABCS |
| 12/12/2011 11:23:10 AM | |
| Breast Cancer Progression Slowed Among Patients Taking Zoledronic Acid Long Term: Presented at SABCS |
| 12/08/2011 04:31:06 PM | |
| Everolimus Plus Exemestane Improves Survival in Tough-to-Treat Advanced Breast Cancer: Presented at SABCS |
| 12/08/2011 02:49:50 PM | |
| CDC Issues Recommendations on Use of New Treatment Option for Latent TB Infection |
| 12/08/2011 02:40:17 PM | |
| Physicians Should Weigh Benefit/Risk Ratio Carefully Before Prescribing Topiramate to Pregnant Women: Presented at AES |
| 12/08/2011 01:07:59 PM | |
| Eslicarbazepine Well Tolerated as Adjunctive Therapy to Various Antiepileptic Drugs: Presented at AES |
| 12/08/2011 12:01:47 PM | |
| Ganaxolone Well Tolerated as Add-on Therapy in Patients With Uncontrolled Partial Seizures: Presented at AES |
| 12/07/2011 04:35:06 PM | |
| Adjunct Treatment With Eslicarbazepine Reduces Seizure Frequency in Patients With Partial-Onset Seizures: Presented at AES |
| 12/07/2011 04:15:56 PM | |
| Novel Extended-Release Formulation of Oxcarbazepine Safe, Effective in Patients With Partial Seizures: Presented at AES |
| 12/07/2011 02:32:13 PM | |
| FDA: Dabigatran Provides ‘Important Health Benefit’ Despite Bleeding Risk |
| 12/07/2011 12:18:50 PM | |
| Vildagliptin Approved in EU for Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment |
| 12/06/2011 03:30:48 PM | |
| Poorly Contracting Uterus in Women With Diabetes Increases Risk of Caesarean Birth |
| 12/06/2011 01:09:17 PM | |
| Clobazam Reduces Drop Seizures in Patients With Lennox-Gastaut Syndrome: Presented at AES |
| 12/06/2011 12:51:48 PM | |
| Perampanel Decreases Seizure Frequency, Increases Responder Rates in Patients With Severe Seizures: Presented at AES |
| 12/06/2011 12:20:01 PM | |
| Lacosamide Reduces Seizure Frequency, Maintains Efficacy Over 8 Years: Presented at AES |
| 11/30/2011 02:44:08 PM | |
| Self-Monitoring of Anticoagulation Therapy Reduces Risk of Thromboembolic Events |
| 11/29/2011 02:59:40 PM | |
| Everolimus Prolongs Progression-Free Survival in Patients With Neuroendocrine Tumours |
| 11/29/2011 11:32:32 AM | |
| European Commission Approves New Combination Therapy for Type 2 Diabetes |
| 11/28/2011 03:55:07 PM | |
